Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €13.69 | €23.46 | 71.457% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.56 | €55.00 | 4.642% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.68 | €4.63 | 578.286% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Bruker Corp. | 7 | 1 | 0 | 1 | €68.62 | €85.68 | 24.868% |
| Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.75 | €8.27 | 22.560% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Boston Scientific | 46 | 0 | 10 | 0 | €68.00 | €73.05 | 7.422% |
| Blueprint Medicines Corp | 2 | 0 | 2 | 0 | €101.20 | - | - |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.80 | €102.62 | 33.618% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €204.50 | €294.01 | 43.771% |
| Biocryst Pharmaceuticals | 10 | 0 | 3 | 0 | €4.75 | €11.05 | 132.524% |
| BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €151.00 | €255.89 | 69.464% |
| Becton, Dickinson & Co. | 9 | 0 | 1 | 0 | €217.30 | €268.91 | 23.749% |
| Bayer AG | 15 | 1 | 1 | 0 | €28.50 | €50.00 | 75.439% |
| Bastide Le Confort | 1 | 0 | 1 | 0 | €19.50 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €70.50 | €100.00 | 41.844% |
| Axonics Modulation Technologies Inc | 9 | 0 | 0 | 0 | €62.00 | €66.53 | 7.305% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.51 | €10.00 | 562.252% |
| Atossa Genetics Inc | 5 | 1 | 1 | 0 | €1.57 | €3.72 | 137.143% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €142.90 | €165.00 | 15.465% |